Department of Radiology, Safa Private Hospital, Istanbul, Turkey.
Surgery, Safa Private Hospital, Istanbul, Turkey.
Curr Med Imaging. 2023;19(6):612-622. doi: 10.2174/1573405619666221209114218.
Colorectal cancer is a malignancy that affects the gastrointestinal tract. Clinical diagnosis has routinely been done with colonoscopy in conjunction with digital rectal and histological examinations.
We show that CT, MRI, and MRI-DWI are all effective in T-staging colorectal adenocarcinoma when compared to pathology examination. However, differences in the detection and diagnostic agreement rates between the imaging modalities for the specific T-stages were observed.
Fifty-six patients diagnosed with colorectal adenocarcinoma and underwent contrastenhanced abdominal CT, non-contrast MRI, or MRI-DWI between January 2014 and March 2020 were retrospectively examined and compared to a biopsy or postoperative pathological T-stage.
The total diagnostic agreement rate for CT, MRI, and MRI-DWI were 58.93%, 76.79%, and 85.71%, respectively. T-staging was statistically and significantly different across all four stages analyzed for all imaging modalities. The T1-stage for MRI and MRI-DWI compared to pathology rates were statistically significant, whereas MRI-DWI and CT both demonstrated statistical significance for T3 and T2 stage comparison, respectively. Furthermore, a statistical and significant difference between the total stage comparison of MRI, MRI-DWI, and CT compared individually to pathology was also observed. All imaging modalities were able to statistically and significantly identify tumors based on tumor size according to the ROC analysis.
These data suggest that CT, MRI, and MRI-DWI can identify and aid visually in the diagnosis of adenocarcinoma colorectal cancer. MRI-DWI is more specific and sensitive in the diagnosis and staging of colorectal tumors.
结直肠癌是一种影响胃肠道的恶性肿瘤。临床诊断通常通过结肠镜检查结合数字直肠和组织学检查进行。
我们表明,与病理检查相比,CT、MRI 和 MRI-DWI 均可有效用于 T 期结直肠腺癌的分期。然而,在观察到的特定 T 分期的成像方式之间,在检测和诊断一致性率方面存在差异。
回顾性检查了 2014 年 1 月至 2020 年 3 月期间经增强腹部 CT、非对比 MRI 或 MRI-DWI 诊断为结直肠腺癌并接受治疗的 56 例患者,并将其与活检或术后病理 T 分期进行比较。
CT、MRI 和 MRI-DWI 的总诊断符合率分别为 58.93%、76.79%和 85.71%。所有成像方式在所有四个分析阶段的 T 分期均存在统计学差异。与病理相比,MRI 和 MRI-DWI 的 T1 分期存在统计学差异,而 MRI-DWI 和 CT 分别对 T3 和 T2 分期比较具有统计学意义。此外,还观察到 MRI、MRI-DWI 和 CT 与病理相比的总分期比较之间存在统计学差异。根据 ROC 分析,所有成像方式均能够根据肿瘤大小进行统计学上显著地识别肿瘤。
这些数据表明 CT、MRI 和 MRI-DWI 可以识别并有助于诊断结直肠腺癌。MRI-DWI 在结直肠肿瘤的诊断和分期方面更具特异性和敏感性。